Clinical usefulness of noninvasive fibrosis indices for predicting hepatocellular carcinoma in treatment‐naïve patients with chronic hepatitis B following entecavir therapy-Reference-Cited by-同舟云学术

Clinical usefulness of noninvasive fibrosis indices for predicting hepatocellular carcinoma in treatment‐naïve patients with chronic hepatitis B following entecavir therapy

Published:2021-07-19 Issue:9 Volume:51 Page:923-932
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Jeong Joonho¹,Shin Jung Woo¹,Jung Seok Won¹,Lee Seung Bum¹,Park Eun Ji²,Park Neung Hwa¹²

Affiliation:

1. Department of Internal Medicine University of Ulsan College of Medicine Ulsan University Hospital Ulsan Korea

2. Biomedical Research Center University of Ulsan College of Medicine Ulsan University Hospital Ulsan Korea

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13690

Reference29 articles.

1. A collaborative strategy to tackle tuberculosis in England

2. The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy

3. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

4. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease

5. Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of the Fibrosis‐4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients;Hepatology Research;2023-09-06